Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|March 8, 2000
High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center studyM Mitterbauer, K Laczika, M Novak, et al.
Annals of Hematology|August 31, 2000
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)E Reiter, H Greinix, W Rabitsch, et al.
Blood|September 15, 1995
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progressionA Gaiger, T Henn, E Hörth, et al.
Allergy|April 23, 2014
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the diseaseG Hoermann, K V Gleixner, G E Dinu, et al.
Leukemia|February 24, 2001
Prognosis of patients with a second relapse of acute myeloid leukemiaB Stoiser, P Knöbl, C Fonatsch, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
Annals of Hematology|March 22, 2002
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutisH Agis, A Weltermann, C Fonatsch, et al.
Leukemia Research|May 30, 2001
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-ValJ H Jordan, R Fritsche-Polanz, W R Sperr, et al.
Leukemia|May 23, 2001
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphomaM Mitterbauer, P Neumeister, P Kalhs, et al.
Annals of Hematology|December 1, 1996
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemiaI M Huhmann, H H Watzke, K Geissler, et al.
Pageof 6